P-tau217 in Alzheimer’s disease
- 24 March 2022
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 531, 100-111
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's diseaseEMBO Molecular Medicine, 2019
- Biomarkers for Alzheimer's disease: current status and prospects for the futureJournal of Internal Medicine, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Presenilin-1 mutations and Alzheimer’s diseaseProceedings of the National Academy of Sciences, 2017
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseAlzheimer's & Dementia, 2014
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersThe Lancet Neurology, 2013
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- The clinical use of structural MRI in Alzheimer diseaseNature Reviews Neurology, 2010
- Bias in Sensitivity and Specificity Caused by Data-Driven Selection of Optimal Cutoff Values: Mechanisms, Magnitude, and SolutionsClinical Chemistry, 2008
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007